Home
NAMSW
NAMSW News

Latest NewAmsterdam Pharma Company N.V. Warrant (NAMSW) News on July 27, 2024

NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024

GlobeNewswire

4 hours ago

NewAmsterdam Pharma to Announce Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia on Monday, July 29, 2024

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

GlobeNewswire

9 days ago

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors

GlobeNewswire

19 days ago

NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

23 days ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma Announces Issuance of Composition of Matter Patent for Obicetrapib by the United States Patent and Trademark Office

GlobeNewswire

2 months ago

NewAmsterdam Pharma Announces Issuance of Composition of Matter Patent for Obicetrapib by the United States Patent and Trademark Office

Business Wire

2 months ago

Net Asset Value(s)

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

GlobeNewswire

2 months ago

Global Automotive HMI Market Size To Worth USD 75.3 Billion By 2033 l CAGR 12.36%

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Newsfile

2 months ago

RETRANSMISSION: First Hydrogen's FCEV Completes Successful Trial with Amazon

Dstny honored with 'Employee Wellbeing Award'

PR Newswire

2 months ago

Dstny honored with 'Employee Wellbeing Award'

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Business Wire

2 months ago

MOURI Tech Announces Acquisition of Vertisystem, Enhancing IT Service Offerings and Extending Market Presence

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Business Wire

2 months ago

Entrust Enables Governments to Transform Citizen Interactions with Digital Identities

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

GlobeNewswire

2 months ago

Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

PR Newswire

2 months ago

Huawei Reveals How to Reach Premium Asian Tourists at Digital Tourist 2024

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in June

GlobeNewswire

2 months ago

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in June

NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib’s Impact on Key Risk Factors for Cardiovascular Disease at Upcoming Medical Meetings

GlobeNewswire

2 months ago

NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib’s Impact on Key Risk Factors for Cardiovascular Disease at Upcoming Medical Meetings

NewAmsterdam Pharma First Quarter 2024 Earnings: US$1.06 loss per share (vs US$0.50 loss in 1Q 2023)

Simply Wall St.

3 months ago

NewAmsterdam Pharma First Quarter 2024 Earnings: US$1.06 loss per share (vs US$0.50 loss in 1Q 2023)

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

GlobeNewswire

3 months ago

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024

GlobeNewswire

3 months ago

NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024

NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease

GlobeNewswire

4 months ago

NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease

NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer

GlobeNewswire

4 months ago

NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer

NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress

GlobeNewswire

4 months ago

NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress

NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD

GlobeNewswire

5 months ago

NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD

NewAmsterdam Pharma Full Year 2023 Earnings: Revenues Miss Expectations

Simply Wall St.

5 months ago

NewAmsterdam Pharma Full Year 2023 Earnings: Revenues Miss Expectations

GuruFocus.com

5 months ago

NewAmsterdam Pharma Co NV (NAMS) Faces Net Loss in 2023 Despite Clinical Progress

NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March

GlobeNewswire

5 months ago

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March

NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

GlobeNewswire

5 months ago

NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

GlobeNewswire

5 months ago

NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

6 months ago

NewAmsterdam Pharma to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Sidus Space LizzieSat™ Arrives at Vandenberg Space Force Base Ahead of Launch

Business Wire

6 months ago

Sidus Space LizzieSat™ Arrives at Vandenberg Space Force Base Ahead of Launch

Sidus Space Appoints Richard J. Berman to its Board of Directors

Business Wire

6 months ago

Sidus Space Appoints Richard J. Berman to its Board of Directors

Pineapple Financial Inc. Launches eSignature and Advertising Banner Management Software for Mortgage Brokers

PR Newswire

6 months ago

Pineapple Financial Inc. Launches eSignature and Advertising Banner Management Software for Mortgage Brokers

Beneficient Closes Initial Series of Liquidity Transaction Financings of Limited Partner Interests Sourced Through Preferred Liquidity Provider Program (“PLP Program”)

GlobeNewswire

6 months ago

Beneficient Closes Initial Series of Liquidity Transaction Financings of Limited Partner Interests Sourced Through Preferred Liquidity Provider Program (“PLP Program”)

7 Cyclical Penny Stocks Best Positioned for 2024

InvestorPlace

6 months ago

7 Cyclical Penny Stocks Best Positioned for 2024

4 Stocks to Buy as Manufacturing Activity Makes Steady Progress

Zacks

6 months ago

4 Stocks to Buy as Manufacturing Activity Makes Steady Progress

Is BTCS Inc. (BTCS) Outperforming Other Finance Stocks This Year?

Zacks

6 months ago

Is BTCS Inc. (BTCS) Outperforming Other Finance Stocks This Year?

Knightscope Deploys Four New Security Robots at Three Locations

Business Wire

7 months ago

Knightscope Deploys Four New Security Robots at Three Locations

Bridgewater Bancshares, Inc. to Announce Fourth Quarter 2023 Financial Results and Host Earnings Conference Call

Business Wire

7 months ago

Bridgewater Bancshares, Inc. to Announce Fourth Quarter 2023 Financial Results and Host Earnings Conference Call

Mainz Biomed Provides Year-End Corporate Review 2023

GlobeNewswire

7 months ago

Mainz Biomed Provides Year-End Corporate Review 2023

NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors

GlobeNewswire

7 months ago

NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors

NewAmsterdam Pharma Announces 2024 Strategic Priorities

GlobeNewswire

7 months ago

NewAmsterdam Pharma Announces 2024 Strategic Priorities

Institutions own 18% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares but private equity firms control 52% of the company

Simply Wall St.

7 months ago

Institutions own 18% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares but private equity firms control 52% of the company

Business Wire

7 months ago

Enveric Biosciences Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.8 Million Gross Proceeds Priced At-the-Market

Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results

GlobeNewswire

7 months ago

Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results

Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering

PR Newswire

7 months ago

Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering

Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series

Business Wire

7 months ago

Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series

Gulf Resources Inc Insider Sells Company Shares

GuruFocus.com

7 months ago

Gulf Resources Inc Insider Sells Company Shares

The Returns On Capital At Tantech Holdings (NASDAQ:TANH) Don't Inspire Confidence

Simply Wall St.

7 months ago

The Returns On Capital At Tantech Holdings (NASDAQ:TANH) Don't Inspire Confidence

Mary Ann Halford Appointed to Cineverse Board of Directors

PR Newswire

7 months ago

Mary Ann Halford Appointed to Cineverse Board of Directors

Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

GlobeNewswire

7 months ago

Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

U.S. Global Investors Reports Financial Results for the First Quarter of 2024 Fiscal Year

GlobeNewswire

7 months ago

U.S. Global Investors Reports Financial Results for the First Quarter of 2024 Fiscal Year

Loop Media (LPTV) Reports Q4 Loss, Lags Revenue Estimates

Zacks

7 months ago

Loop Media (LPTV) Reports Q4 Loss, Lags Revenue Estimates

Cyclacel Pharmaceuticals Announces Reverse Stock Split

GlobeNewswire

7 months ago

Cyclacel Pharmaceuticals Announces Reverse Stock Split

Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data

Investor's Business Daily

8 months ago

Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data

Great Elm Capital Corp. (“GECC”) Extends Revolving Credit Facility, Lowers Cost of Capital

GlobeNewswire

8 months ago

Great Elm Capital Corp. (“GECC”) Extends Revolving Credit Facility, Lowers Cost of Capital

Wall Street Analysts See a 74.13% Upside in Aris Water Solutions, Inc. (ARIS): Can the Stock Really Move This High?

Zacks

8 months ago

Wall Street Analysts See a 74.13% Upside in Aris Water Solutions, Inc. (ARIS): Can the Stock Really Move This High?

Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Business Wire

8 months ago

Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire

8 months ago

Jianpu Technology Inc. Reports Third Quarter 2023 Unaudited Financial Results

5 REITs Under $5 Making Huge Gains This Month

Benzinga

8 months ago

5 REITs Under $5 Making Huge Gains This Month

PR Newswire

8 months ago

Jianpu Technology Inc. to Report Third Quarter 2023 Financial Results on Friday, November 24, 2023

News Direct

8 months ago

Four Solar Sector Stocks Set To Soar in 2024

OSS Wins U.S. Government Program for AI Compute and Storage Solution

GlobeNewswire

8 months ago

OSS Wins U.S. Government Program for AI Compute and Storage Solution

United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI

GlobeNewswire

8 months ago

United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI

Laird Superfood, Inc. (AMEX:LSF) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Laird Superfood, Inc. (AMEX:LSF) Q3 2023 Earnings Call Transcript

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

Business Wire

8 months ago

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

AmpliTech to Host Quarterly Investor Call to Review Q3 2023 Earnings on Tuesday November 14, 4:30 PM ET; Dial-in # 1-833-630-0019 or 1-412-317-1807

ACCESSWIRE

8 months ago

AmpliTech to Host Quarterly Investor Call to Review Q3 2023 Earnings on Tuesday November 14, 4:30 PM ET; Dial-in # 1-833-630-0019 or 1-412-317-1807

Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter 2023 Financial Highlights

GlobeNewswire

8 months ago

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter 2023 Financial Highlights

Pineapple Energy Inc. (NASDAQ:PEGY) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Pineapple Energy Inc. (NASDAQ:PEGY) Q3 2023 Earnings Call Transcript

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) Q3 2023 Earnings Call Transcript

Century Casinos, Inc. (NASDAQ:CNTY) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Century Casinos, Inc. (NASDAQ:CNTY) Q3 2023 Earnings Call Transcript

Associated Press Finance

9 months ago

Paramount Gold: Fiscal Q1 Earnings Snapshot

Greenpro Incubated Company Brighsun EV Group to Drive ESG Initiatives Through its Core Recyclable Battery Technologies

ACCESSWIRE

9 months ago

Greenpro Incubated Company Brighsun EV Group to Drive ESG Initiatives Through its Core Recyclable Battery Technologies

Paramount’s Grassy Mountain Receives Notice to Proceed From Oregon State Regulators

GlobeNewswire

9 months ago

Paramount’s Grassy Mountain Receives Notice to Proceed From Oregon State Regulators

Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results

GlobeNewswire

9 months ago

Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results

Usio, Inc. Card Issuing Division Launches Its First State-Administered Prepaid Card Program

Business Wire

9 months ago

Usio, Inc. Card Issuing Division Launches Its First State-Administered Prepaid Card Program

Multi Ways Holdings Announces First Half 2023 Unaudited Financial Results, Provides Corporate Updates

GlobeNewswire

9 months ago

Multi Ways Holdings Announces First Half 2023 Unaudited Financial Results, Provides Corporate Updates

Share on Social Networks: